Lit Matters 2: Early norepi for septic shock

Septic shock is not just hypovolemia; vasoplegia and inflammatory vascular dysfunction make prolonged hypotension dangerous even while fluids are still running. Early norepinephrine appears safe and may improve survival, organ perfusion, and fluid balance in sepsis resuscitation.

Early norepinephrine in septic shock

• Vasoplegia-driven shock physiology: Septic shock is an afterload problem as much as a volume problem, with cytokine-mediated vasodilation making blind fluid loading an incomplete resuscitation strategy.
• Timing signal for norepinephrine: Starting norepinephrine within 3 hours was associated with lower 28-day mortality than later initiation, a clinically meaningful survival signal in this retrospective cohort.
• Fluid-sparing resuscitation effect: Early norepinephrine was linked to far less fluid exposure, with roughly 18 mL/kg versus 79 mL/kg, supporting pressors as a way to limit overload while restoring perfusion.
• Organ support and recovery: Earlier norepinephrine correlated with fewer ventilator days, more pressor-free days, and less AKI and organ failure progression, benefits we put in bedside context in the episode.
• Delay carries measurable risk: A prior septic shock cohort found mortality rose with norepinephrine delay, about 5.3% for each hour within the first 6 hours, reinforcing that waiting is not benign.
• Practical safety reassurance: The main concern with earlier pressors is complication burden, yet this analysis found similar peak norepinephrine requirements and a shorter overall duration of vasopressor use.